We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Protein Biomarker Identifies Damaged Brain Wiring After Concussion

By LabMedica International staff writers
Posted on 08 Dec 2015
Mild traumatic brain injury (TBI) or concussion is often defined as a brief loss of normal brain function typically following a blow to the head and is by far the most common form of TBI and frequently does not even receive medical attention.

A brain protein called alpha II-spectrin N-terminal fragment (SNTF), which rises in the blood after some concussions, signals the type of brain damage that is thought to be the source of cognitive impairments, and may be useful as a biomarker of permanent axonal injury. More...


Scientists at University of Pennsylvania School of Medicine (Philadelphia, PA, USA) selected TBI cases to include 18 patients who died acutely following severe TBI, with survival times ranging from six hours to one week. Detailed reports from the diagnostic autopsy and/or forensic reports were available for all cases and indicated a history of a single severe TBI, supported by autopsy findings. TBI cases were compared to material from 16 age/sex-matched controls, acquired at routine diagnostic post-mortem at the same institution. Controls had no documented history of TBI.

Paraffin-embedded tissue from human postmortem studies was subjected to routine histology including hematoxylin and eosin (H&E) staining as well as immunohistological techniques. A synthetic peptide corresponding to the calpain-generated neoepitope in SNTF (CAQQEVY) was conjugated covalently to maleimide-activated Sepharose via the cysteine side chain and the resulting resin used for affinity purification of SNTF-specific antibodies. Adjacent, serial sections were labeled with an antibody reactive for the N-terminal amino acids 66–81 of the amyloid precursor protein (APP). Some sections were coverslipped using fluorescence mounting medium and visualized using a confocal Eclipse Ti microscope (Nikon; Tokyo, Japan).

Immunohistochemistry (IHC) specific for SNTF was compared to that of amyloid precursor protein (APP), the current standard for diffuse axonal injury (DAI) diagnosis, and other known markers of axonal pathology including non-phosphorylated neurofilament-H (SMI-32), neurofilament-68 (NF-68) and compacted neurofilament-medium (RMO-14) using double and triple immunofluorescent labeling. Supporting its use as a biomarker of DAI, SNTF immunoreactive axons were observed at all time points following both human severe TBI and in the model of mild TBI.

Robert Siman, PhD, a coauthor of the study, said, “The study suggests that we may soon have a blood biomarker for concussion akin to the standard blood test used to detect cardiac damage from heart attacks. SNTF in the blood of a concussed individual may provide a specific diagnosis of diffuse axonal injury as well as the process of axonal degeneration. The study was published on November 20, 2015, in the journal Acta Neuropathologica.

Related Links:

University of Pennsylvania School of Medicine 
Nikon 



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
PlGF Test
Quidel Triage PlGF Test
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.